Invention Grant
- Patent Title: Releasable GLP-1 conjugates
-
Application No.: US17559692Application Date: 2021-12-22
-
Publication No.: US11957735B2Publication Date: 2024-04-16
- Inventor: Marek Kwiatkowski , Christian Sund
- Applicant: QuiaPEG Pharmaceuticals AB
- Applicant Address: SE Uppsala
- Assignee: QuiaPEG Pharmaceuticals AB
- Current Assignee: QuiaPEG Pharmaceuticals AB
- Current Assignee Address: SE Uppsala
- Agency: Fish & Richardson P.C.
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/26 ; A61K47/60

Abstract:
The present application provides compounds of Formula (I):
or pharmaceutically acceptable salts thereof, wherein D is a residue of a GLP-polypeptide or an analog thereof, which underdo hydrolysis under physiological conditions to release the GLP-polypeptide or analog thereof and which are useful in the treatment of disorders that could be beneficially treated with the GLP-polypeptide or analog thereof.
or pharmaceutically acceptable salts thereof, wherein D is a residue of a GLP-polypeptide or an analog thereof, which underdo hydrolysis under physiological conditions to release the GLP-polypeptide or analog thereof and which are useful in the treatment of disorders that could be beneficially treated with the GLP-polypeptide or analog thereof.
Public/Granted literature
- US20220118055A1 RELEASABLE GLP-1 CONJUGATES Public/Granted day:2022-04-21
Information query
IPC分类: